APA (7th ed.) Citation

K, J., C, T., RL, B., PS, H., B, S., H, K., . . . L, T. (2025). Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness. International journal of molecular sciences, 26(21), . https://doi.org/10.3390/ijms262110760

Chicago Style (17th ed.) Citation

K, Jennings, Tian C, Brown RL, Horn PS, Schoser B, Kushlaf H, Timchenko NA, and Timchenko L. "Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness." International Journal of Molecular Sciences 26, no. 21 (2025). https://doi.org/10.3390/ijms262110760.

MLA (9th ed.) Citation

K, Jennings, et al. "Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness." International Journal of Molecular Sciences, vol. 26, no. 21, 2025, https://doi.org/10.3390/ijms262110760.